Literature DB >> 24637000

Faecal haemoglobin concentrations vary with sex and age, but data are not transferable across geography for colorectal cancer screening.

Callum G Fraser, Tiziana Rubeca, Stefano Rapi, Li-Sheng Chen, Hsiu-Hsiu Chen.   

Abstract

BACKGROUND: Faecal immunochemical tests (FIT) are becoming widely used in colorectal cancer (CRC) screening. Availability of data on faecal haemoglobin concentrations (f-Hb) in three countries prompted an observational study on sex and age and the transferability of data across geography.
METHODS: Single estimates of f-Hb in large groups were made in Scotland, Taiwan and Italy using quantitative automated immunoturbidimetry on the Eiken OC-Sensor. Distributions were examined for men and women overall and in four different age groups.
RESULTS: The distributions of f-Hb were not Gaussian and had kurtosis and positive skewness. The distributions were different in the three countries: f-Hb varies with sex and age in all countries, being higher in men and the elderly, but the degree of variation is inconsistent across countries, f-Hb being higher in Scotland than in Taiwan than in Italy, possibly due to different lifestyles. At any cut-off concentration, more men are declared positive than women and more older people are declared positive than younger individuals.
CONCLUSIONS: Our analysis supports the view that setting and using a single f-Hb cut-off in any CRC screening programme is far from ideal. We suggest that individualisation is the optimum approach with f-Hb, alone or with other important factors such as sex and age, used to determine important personal issues such as need for colonoscopy, screening interval between tests and risk of future CRC. Whether there is merit in monitoring f-Hb in individuals over time remains an interesting research question for the future.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24637000     DOI: 10.1515/cclm-2014-0115

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  18 in total

1.  Low Sensitivity of Fecal Immunochemical Tests (FIT) for Detection of Sessile Serrated Adenomas/Polyps Confirmed Over Clinical Setting, Geography, and FIT System.

Authors:  Craig Mowat; Jayne Digby; Judith A Strachan; Robert J C Steele; Callum G Fraser
Journal:  Dig Dis Sci       Date:  2019-05-18       Impact factor: 3.199

2.  Faecal immunochemical testing in general practice.

Authors:  Nigel D'Souza; Anthony Brzezicki; Muti Abulafi
Journal:  Br J Gen Pract       Date:  2019-02       Impact factor: 5.386

3.  The diagnostic accuracy of the faecal immunochemical test for colorectal cancer in risk-stratified symptomatic patients.

Authors:  N D'Souza; G Hicks; S C Benton; M Abulafi
Journal:  Ann R Coll Surg Engl       Date:  2019-11-07       Impact factor: 1.891

4.  Interval cancers in a national colorectal cancer screening programme.

Authors:  Robert Jc Steele; Greig Stanners; Jaroslaw Lang; David H Brewster; Francis A Carey; Callum G Fraser
Journal:  United European Gastroenterol J       Date:  2016-01-06       Impact factor: 4.623

5.  Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study.

Authors:  Kevin Selby; Christopher D Jensen; Jeffrey K Lee; Chyke A Doubeni; Joanne E Schottinger; Wei K Zhao; Jessica Chubak; Ethan Halm; Nirupa R Ghai; Richard Contreras; Celette Skinner; Aruna Kamineni; Theodore R Levin; Douglas A Corley
Journal:  Ann Intern Med       Date:  2018-09-18       Impact factor: 25.391

6.  Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase.

Authors:  Gian Paolo Caviglia; Luca Cabianca; Sharmila Fagoonee; Fabrizio M Gili
Journal:  Biochem Med (Zagreb)       Date:  2016       Impact factor: 2.313

7.  The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer.

Authors:  James L Turvill; Daniel Turnock; Dan Cottingham; Monica Haritakis; Laura Jeffery; Annabelle Girdwood; Tom Hearfield; Alex Mitchell; Ada Keding
Journal:  Br J Gen Pract       Date:  2021-07-29       Impact factor: 6.302

Review 8.  Advances in Fecal Occult Blood Tests: the FIT revolution.

Authors:  Graeme P Young; Erin L Symonds; James E Allison; Stephen R Cole; Callum G Fraser; Stephen P Halloran; Ernst J Kuipers; Helen E Seaman
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

Review 9.  Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance.

Authors:  Marie Westwood; Shona Lang; Nigel Armstrong; Sietze van Turenhout; Joaquín Cubiella; Lisa Stirk; Isaac Corro Ramos; Marianne Luyendijk; Remziye Zaim; Jos Kleijnen; Callum G Fraser
Journal:  BMC Med       Date:  2017-10-24       Impact factor: 8.775

10.  Preliminary Results: Colorectal Cancer Screening Using Fecal Immunochemical Test (FIT) in a Thai Population Aged 45-74 Years: A Population-Based Randomized Controlled Trial

Authors:  Pongdech Sarakarn; Supannee Promthet; Patravoot Vatanasapt; Nakhon Tipsunthonsak; Kriangsak Jenwitheesuk; Naowarat Maneenin; Chananya Jirapornkul; Siriporn Kamsa-ard; Tiptiya Haengsorn; Channarong Arkkhaboot; Sam Li-Sheng Chen; Amy Ming-Fang Yen; Sherry Yueh-Hsia Chiu; Jean Ching-Yuan Fann; Tony Hsiu-Hsi Chen
Journal:  Asian Pac J Cancer Prev       Date:  2017-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.